Cargando…

Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis

OBJECTIVES: To investigate the clinical features of thrombotic microangiopathy associated with allogeneic hematopoietic stem cell transplantation in children. METHODS: A retrospective analysis of continuous clinical data from HSCT received in the Department of Hematology and Oncology of Wuhan Childr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Linlin, Xiong, Hao, Chen, Zhi, Yang, Li, Sun, Ming, Lu, Wenjie, Tao, Fang, Wang, Zhuo, Li, Jianxin, Li, Zuofeng, Tang, Sujie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293339/ https://www.ncbi.nlm.nih.gov/pubmed/36973479 http://dx.doi.org/10.1007/s12094-023-03129-1

Ejemplares similares

P1344: METHODOLOGY OF AN INTERNATIONAL MULTI-CENTER RETROSPECTIVE REVIEW OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) BY THE TA-TMA WORKING GROUP
por: Ho, V., et al.
Publicado: (2022)

P1321: CLINICAL ANALYSIS OF THE RELATIONSHIP BETWEEN PLASMA SC5B-9 LEVEL AND TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) IN PEDIATRIC PATIENTS
por: Luo, Linlin, et al.
Publicado: (2023)

Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
por: Ponraj, Royston, et al.
Publicado: (2023)

Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand
por: Lazana, Ioanna
Publicado: (2023)

A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
por: Addad, Vanessa Vilani, et al.
Publicado: (2023)

Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
por: Afrouzian, Marjan, et al.
Publicado: (2023)

Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation
por: Sevindik, Ömür Gökmen, et al.
Publicado: (2015)

Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies
por: Font, Carme, et al.
Publicado: (2022)

Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
por: Afrouzian, Marjan, et al.
Publicado: (2023)

A case of transplantation-associated thrombotic microangiopathy with autopsy-proven fatal myocardial ischemia after allogeneic hematopoietic stem cell transplantation
por: Sasaki, Ken, et al.
Publicado: (2020)

Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management
por: Dvorak, Christopher C., et al.
Publicado: (2019)

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
por: Coppo, Paul, et al.
Publicado: (2010)

Variable clinical manifestations of hematopoietic stem cell transplant‐associated thrombotic microangiopathy
por: Jia, Chenguang, et al.
Publicado: (2019)

Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy
por: Gomez-Ganda, Laura, et al.
Publicado: (2021)

Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment
por: Rosenthal, Joseph
Publicado: (2016)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy
por: Ardissino, Gianluigi, et al.
Publicado: (2022)

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy and the role of advanced practice providers and pharmacists
por: Mahmoudjafari, Zahra, et al.
Publicado: (2023)

Thrombotic Microangiopathy in Haematopoietic Cell Transplantation: an Update
por: Stavrou, Evi, et al.
Publicado: (2010)

Characteristics and management of thrombotic microangiopathy in kidney transplantation
por: Cho, Wonyong, et al.
Publicado: (2023)

Narsoplimab for severe transplant-associated thrombotic microangiopathy
por: Pandrowala, Ambreen, et al.
Publicado: (2023)

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports
por: Hsu, Ping-Chih, et al.
Publicado: (2023)

Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma
por: Sabulski, Anthony, et al.
Publicado: (2023)

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Lessons for the clinical nephrologist: recurrent pregnancy-associated thrombotic microangiopathy (TMA) with a known complement mutation and features of preeclampsia; a diagnostic and therapeutic dilemma
por: Smith, Priscilla, et al.
Publicado: (2021)

Thrombotic microangiopathy following haematopoietic stem cell transplant
por: Seaby, Eleanor G., et al.
Publicado: (2017)

Cerebral vascular injury in transplant-associated thrombotic microangiopathy
por: Sabulski, Anthony, et al.
Publicado: (2022)

Thrombotic Microangiopathy With Granulomatosis Interstitial Nephritis in an Allogenic Bone Marrow Transplant Patient: A Case Report and Review of the Literature
por: Mirza, Abu-Sayeef, et al.
Publicado: (2017)

Serious Hemorrhagic Complications After Successful Treatment of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy With Defibrotide in Pediatric Patient With Myelodysplastic Syndrome
por: Laberko, Alexandra, et al.
Publicado: (2020)

Kidney-Predominant Thrombotic Microangiopathy Associated With TREX1 Frameshift Mutation
por: Song, Zhuo-ran, et al.
Publicado: (2023)

Renal Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: Involvement of Chronic Graft-Versus-Host Disease
por: Mii, Akiko, et al.
Publicado: (2018)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Thrombotic Microangiopathy in a Severe Pediatric Case of COVID-19
por: Dalkıran, Tahir, et al.
Publicado: (2021)

Post transplant thrombotic microangiopathy causing acute renal failure
por: Qutube, S., et al.
Publicado: (2009)

Doxycycline for haematopoietic stem cell transplantation-related thrombotic microangiopathy
por: Izzedine, Hassane, et al.
Publicado: (2010)

Thrombotic Microangiopathy in a Kidney Transplant Patient With COVID-19
por: Bascuñana, Arturo, et al.
Publicado: (2020)

Thrombotic Microangiopathy Associated with Pazopanib in a Kidney Transplant Recipient
por: Kalla, Shabana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pdpke53e50pgaksp5m3pv7a3bg